EUVIMEDScopri EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021)

Matthew M E Steele iD, Marit F van den Berg iD, Sara Galac iD, Ana M Dordio, Anna Threlfall, Cláudia Gomes, Amanda Paul, Mirja Nolff, Nadja Sieber-Ruckstuhl iD, Ghita Benchekroun iD, Fergus Allerton, Beatriz Mendoza and 28 more

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.70220 ↗

At a glance

Multizentrische Studie in Journal of Veterinary Internal Medicine, 2025. Written by Matthew M E Steele and 39 co-authors. Institution: ChesterGates Veterinary Specialists, Chester, UK. Major MEDLINE topics: Pheochromocytoma, Dog Diseases, Adrenal Gland Neoplasms, Adrenalectomy. Cited 3 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Small Animal Medicine Society.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The survival of dogs with pheochromocytoma (PCC) treated with adrenoreceptor antagonists has not been described or compared to surgically managed cases. Hypothesis/Objectives The objective of this study is to evaluate the survival of medically and surgically managed dogs with PCC and investigate factors associated with survival. Animals Two hundred fifty-five dogs with PCC, treated with alpha-adrenoreceptor antagonists (AA) without adrenalectomy (Group 1, n = 75), adrenalectomy +/– AA (Group 2, n = 128), or neither treatment (Group 3, n = 52).

Methods

Retrospective, multicenter review of medical records. Median overall survival time (OST) for Groups 1 and 2 combined was calculated using Kaplan–Meier estimates, and then compared between Group 1 and Group 2 using Log-Rank testing. Cox proportional hazard analysis identified factors associated with survival in Groups 1 and 2 individually and combined.

Results

Median OST for all cases was 854 (95% CI: 572–1136) days. Median OST was lower in Group 1 (247 days, 95% CI: 76–418 days) than in Group 2 (927 days, 95% CI: 587–1267 days; p < 0.001). In Group 2, 88/92 dogs (97.8%) that received presurgical AA treatment survived to discharge compared to 23/27 (85.2%) that did not receive AA pretreatment (p = 0.03). Lack of clinical signs at presentation was associated with increased survival in both groups combined (HR 0.5; 95% CI 0.3–0.9; p = 0.02) and in Group 2 alone (HR 0.3; 95% CI 0.1–0.7; p = 0.01). Conclusions and Clinical Importance Dogs with PCC treated with adrenalectomy have longer survival compared to those managed with AA without adrenalectomy.

Subjects

MeSH terms (MEDLINE)

PheochromocytomaDog DiseasesAdrenal Gland NeoplasmsAdrenalectomyAdrenergic alpha-AntagonistsAnimalsDogsRetrospective StudiesMaleFemaleSurvival Analysis

Author keywords

adrenaladrenalectomyendocrinemetanephrinephenoxybenzamine

Substances

Adrenergic alpha-Antagonists

Authors and institutions

  • ChesterGates Veterinary Specialists, Chester, UK.
  • Clinical Science and Services, Royal Veterinary College, London, UK.
  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • Davies Veterinary Specialists, Hitchin, UK.
  • Anderson Moores Veterinary Specialists, Winchester, UK.
  • The Queens Veterinary School Hospital, University of Cambridge, Cambridge, UK.

ORCID profiles: Matthew M E Steele, Marit F van den Berg, Sara Galac, Nadja Sieber-Ruckstuhl, Ghita Benchekroun, Alisdair Boag, Federico Fracassi, Alejandra Carranza Valencia, Jorge Pena-Ramos, Romy M Heilmann, Paolo Silverstrini, Carolina Arenas, Mario Cervone, Rodolfo O Leal, Anaïs Lamoureux, Ruth Gostelow

Funding

  • Small Animal Medicine Society

Cite

APA

Steele, M. M. E., van den Berg, M. F., Galac, S., Dordio, A. M., Threlfall, A., Gomes, C., Paul, A., Nolff, M., Sieber-Ruckstuhl, N., Benchekroun, G., Allerton, F., Mendoza, B., Spence, S., Valiente, P., Boag, A., Fracassi, F., Carranza Valencia, A., Pena-Ramos, J., Lloyd-Bradley, B., …, & Gostelow, R. (2025). A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021). Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70220

Vancouver

Steele MME, van den Berg MF, Galac S, Dordio AM, Threlfall A, Gomes C, et al. A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021). Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70220

BibTeX
@article{Steele2025,
  author = {Steele, Matthew M E and van den Berg, Marit F and Galac, Sara and Dordio, Ana M and Threlfall, Anna and Gomes, Cláudia and Paul, Amanda and Nolff, Mirja and Sieber-Ruckstuhl, Nadja and Benchekroun, Ghita and Allerton, Fergus and Mendoza, Beatriz and Spence, Susanna and Valiente, Paula and Boag, Alisdair and Fracassi, Federico and Carranza Valencia, Alejandra and Pena-Ramos, Jorge and Lloyd-Bradley, Ben and Seth, Mayank and Fawsitt, Jack and Yu Foo, Fang and Heilmann, Romy M and Silverstrini, Paolo and Lyssens, Aurélie and Vangrinsven, Emilie and Casas-Acuna, Clara and Hrovat, Alenka and Arenas, Carolina and Cervone, Mario and Mooney, Carmel T and Leal, Rodolfo O and Piekos, Karolina Maria and Olivares, Gerard and Ruiz, Guillame and Caulfield, Sarah J and Keyte, Sophie and Lamoureux, Anaïs and Scudder, Christopher J and Gostelow, Ruth},
  title = {A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021)},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.70220}
}
Start for free →